Concepedia

Lionel Hovsepian

LH

Statistics

Publications

8

Citations

291

H-Index

8

Active since

2007

Affiliations

Sanofi (France)(Current)

AVEO Oncology (United States)

Sanofi (United States)

Drugs for Neglected Diseases Initiative

Lionel Hovsepian is an author at Sanofi (France) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2007–2023

8

Publications

8

Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies

Antoine Tarral, Séverine Blesson, Olaf Valverde Mordt et al. · Clinical Pharmacokinetics · 2014 · 97 citations · Full text

, , +15

Safety and Pharmacokinetics of Paracetamol Following Intravenous Administration of 5 g During the First 24 h with a 2-g Starting Dose

Nicolas Grégoire, Lionel Hovsepian, Virginie Gualano et al. · Clinical Pharmacology & Therapeutics · 2007 · 62 citations

, , +15

Pharmacokinetic evaluation of linezolid in patients with major thermal injuries

Andrew Lovering, R. Le Floch, Lionel Hovsepian et al. · Journal of Antimicrobial Chemotherapy · 2009 · 34 citations · Full text

, , +7

Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study

Antoine Tarral, Lionel Hovsepian, Thierry Duvauchelle et al. · Clinical Pharmacokinetics · 2023 · 30 citations · Full text

, , +15

Functional variability of platelet response to clopidogrel correlates with P2Y12 receptor occupancy

Claire Bal dit Sollier, Natacha Berge, Bernadette Boval et al. · Thrombosis and Haemostasis · 2008 · 28 citations

, , +17

1–5 of 8